Sechenov School
Home › Pharmacology › Prazosin: First-Dose Phenomenon and Dosing

Prazosin

Prazosinum

For medical students2 min readUpdated 2026-10-10

Prazosin is a drug that requires extreme caution at the initiation of therapy due to the high risk of a sudden drop in blood pressure. The main clinical challenge when prescribing it is the development of the so-called first-dose phenomenon, which dictates strict rules for selecting the starting dose and timing of administration.

Main RiskFirst-dose phenomenon (sudden drop in blood pressure)
IncidenceOccurs in 25% of patients starting therapy
Timing of AdministrationStrictly in the evening (before bedtime)
Starting DoseThreshold dose (½ tablet)

First-Dose Phenomenon

A key feature that determines the management strategy for Prazosinum is the development of the first-dose phenomenon. This condition is a sharp, unpredictable drop in blood pressure that occurs in response to the very first administration of the medication.

According to statistical data, this reaction is recorded in every fourth patient (exactly 25% of patients) initiating therapy. It is precisely this high risk that obligates the physician to observe strict precautionary measures and apply a specific dosing algorithm to avoid dangerous complications associated with sudden hypotension.

Choosing the Starting Dose: Why the Threshold Dose?

In pharmacological practice, there are several types of dosages, but a correct start is critically important for Prazosinum. According to prescribing rules, therapy must categorically not be started with loading doses (which are used to rapidly achieve a high concentration) or immediately with standard therapeutic doses. Maintenance doses are also out of the question at the initial stage.

The only correct tactic is to start with threshold doses. A threshold dose is the minimum amount of a substance capable of eliciting an initial biological response. In practice, the patient is prescribed only ½ of a tablet. Ignoring this rule and choosing a loading dose or full therapeutic dose repeatedly increases the risk of developing severe hypotension upon the first intake.

Timing of Administration and Subsequent Titration

The second crucial aspect of the prescribing strategy is the time of day. The patient must take the first threshold dose (½ tablet) strictly in the evening, immediately before bedtime. The logic behind this prescription is simple: if the patient develops a sharp drop in blood pressure (the phenomenon occurring in 25% of people), remaining in a horizontal position in bed minimizes the risks of injuries and fainting.

After the body successfully tolerates the first dose, the physician moves on to the next stage — gradual titration. Titration means a smooth, step-by-step increase in the drug dosage from the threshold to the target level. A gradual increase in dose allows the cardiovascular system to adapt and prevents recurrent episodes of a sharp blood pressure drop.

Mnemonic

To quickly remember the prescribing strategy, use the "Three P's" rule (or equivalent in English — Threshold dose (half a tablet), Progressive titration, Posture (take in the evening before bed due to the risk of pressure drop)).

Frequently asked questions

In what percentage of patients does the first-dose phenomenon occur when taking prazosin?

This complication, accompanied by a sharp drop in blood pressure, occurs in 25% of patients.

What dose should therapy with Prazosinum be started with?

Treatment is always started exclusively with threshold doses. As a rule, the starting dosage is half (½) of a tablet.

What time of day is optimal to take the first dose and why?

The drug is prescribed in the evening, immediately before bedtime. This is necessary to reduce the risk of injury in the event of a potential sharp drop in blood pressure.

What is done after the successful administration of the starting dose?

After taking the initial threshold dose, a gradual titration strategy is applied. This means the dosage is carefully and step-by-step increased to the required values.

Go deeper

More topics in Pharmacology

Pharmacotherapy of Chagas Disease: NifurtimoxBioavailability and First-Pass EliminationAdverse Drug Reactions: Side Effects and MechanismsBarbiturate PoisoningP2Y12 Receptor AntagonistsHepatoprotective AgentsCoronary Artery Disease: Etiology and PathogenesisThiopental SodiumLipid Transport and LipoproteinsIpratropium BromideEthanolBeta-BlockersPharmacology →